195 related articles for article (PubMed ID: 15967201)
21. Biological degradation of aflatoxins.
Wu Q; Jezkova A; Yuan Z; Pavlikova L; Dohnal V; Kuca K
Drug Metab Rev; 2009; 41(1):1-7. PubMed ID: 19514968
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of human populations for early markers of cadmium toxicity: a review.
Fowler BA
Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
[TBL] [Abstract][Full Text] [Related]
23. Urinary biomarkers of aflatoxin exposure in young children from Egypt and Guinea.
Polychronaki N; Wild CP; Mykkänen H; Amra H; Abdel-Wahhab M; Sylla A; Diallo M; El-Nezami H; Turner PC
Food Chem Toxicol; 2008 Feb; 46(2):519-26. PubMed ID: 17920747
[TBL] [Abstract][Full Text] [Related]
24. Translational strategies for cancer prevention in liver.
Kensler TW; Qian GS; Chen JG; Groopman JD
Nat Rev Cancer; 2003 May; 3(5):321-9. PubMed ID: 12724730
[TBL] [Abstract][Full Text] [Related]
25. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers in environmental carcinogenesis research: striving for a new momentum.
Kyrtopoulos SA
Toxicol Lett; 2006 Mar; 162(1):3-15. PubMed ID: 16321483
[TBL] [Abstract][Full Text] [Related]
27. Aflatoxin is not a probably human carcinogen: the published evidence is sufficient.
Stoloff L
Regul Toxicol Pharmacol; 1989 Dec; 10(3):272-83. PubMed ID: 2690197
[TBL] [Abstract][Full Text] [Related]
28. Aflatoxin biomarkers in hair may facilitate long-term exposure studies.
Mupunga I; Izaaks CD; Shai LJ; Katerere DR
J Appl Toxicol; 2017 Apr; 37(4):395-399. PubMed ID: 27933645
[TBL] [Abstract][Full Text] [Related]
29. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
30. [Exposure to aflatoxin B1 in experimental animals and its public health significance].
Guzmán de Peña D
Salud Publica Mex; 2007; 49(3):227-35. PubMed ID: 17589777
[TBL] [Abstract][Full Text] [Related]
31. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.
Groopman JD; Kensler TW; Wild CP
Annu Rev Public Health; 2008; 29():187-203. PubMed ID: 17914931
[TBL] [Abstract][Full Text] [Related]
32. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
33. Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man.
Kensler TW; Groopman JD; Roebuck BD
Mutat Res; 1998 Jun; 402(1-2):165-72. PubMed ID: 9675269
[TBL] [Abstract][Full Text] [Related]
34. Use of isotope-labeled aflatoxins for LC-MS/MS stable isotope dilution analysis of foods.
Cervino C; Asam S; Knopp D; Rychlik M; Niessner R
J Agric Food Chem; 2008 Mar; 56(6):1873-9. PubMed ID: 18303822
[TBL] [Abstract][Full Text] [Related]
35. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
36. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen.
Albertini RJ
IARC Sci Publ; 2004; (157):153-77. PubMed ID: 15055295
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology: a tool for understanding mechanisms of disease.
Boffetta P
Eur J Surg Suppl; 2002; (587):62-9. PubMed ID: 16144203
[TBL] [Abstract][Full Text] [Related]
39. Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.
Dash B; Afriyie-Gyawu E; Huebner HJ; Porter W; Wang JS; Jolly PE; Phillips TD
J Toxicol Environ Health A; 2007 Jan; 70(1):58-66. PubMed ID: 17162498
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
